Search - tctmd.com

Displaying 61 - 80 of 90

Sort: Relevancy | Date

Presentation TVT 2017

Severe PVL, Caused by Ventricular Migration of Evolut R, Successfully Treated With Sapien-3 Valve-in-Valve

Presenter: David W.M. Muller, Lars Sondergaard, Peter den Heijer, MD

June 16, 2017

Presentation TVT 2017

Evolut R Snapshots II Techniques to Minimize PPM

Presenter: Ariel Finkelstein

June 16, 2017

Presentation TVT 2017

Evolut R Snapshots I - The New Evolut R PRO System

Presenter: John K. Forrest

June 16, 2017

Presentation TVT 2017

The Evolut R TAVR System: A Cool Case, New Technology (Including 34mm), and Clinical Program Updates

Presenter: Jeffrey J. Popma

June 16, 2017

Presentation TVT 2017

TAVR for Pure Aortic Insufficiency (AI) With Prior Ascending Aortic Hemi-shield Repair : Unique Role for EVOLUT-R

Presenter: Albert Markus Kasel, Thomas Walther, Soundos Moualla, MD

June 15, 2017

Presentation TVT 2017

Expert Commentary: Evolut R in Degenerative Surgical Aortic Bioprostheses (VIVA Registry)

Presenter: Ran Kornowski

June 15, 2017

Presentation TVT 2017

A Surgeon/Interventionalists Perspectives of Transcatheter Mitral and Tricuspid Valve Therapies Evolution, Impact, and Future Expectations

Presenter: Mark Reisman, Gregg W. Stone, Francesco Maisano

June 15, 2017

Presentation TVT 2017

Impact of Valvular Heart Disease on the Global Burden of Heart Failure: Can Transcatheter Therapies Make a Difference?

Presenter: Mark Reisman, Gregg W. Stone, Clyde W. Yancy

June 15, 2017

Presentation TVT 2017

TAVR in Perspective Evolution, Impact, and Future Expectations

Presenter: Mark Reisman, Gregg W. Stone, Martin B. Leon

June 15, 2017

Presentation TVT 2017

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

Presenter: Mark Reisman, Gregg W. Stone, Robert O. Bonow

June 15, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Conference News TVT 2016

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

Michael O'Riordan

June 20, 2016

Presentation TVT 2016

Evolution From a TAVR Program to an Aortic Valve Center of Excellence

Presenter: A. Pieter Kappetein

June 18, 2016

News Conference News TVT 2016

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Michael O'Riordan

June 18, 2016

Presentation TVT 2016

Millipede: Evolution of the Concept

Presenter: Jason H. Rogers

June 17, 2016

Presentation TVT 2016

TVT 1039: Transcatheter Aortic Valve Replacement With Evolut-R CoreValve to Simultaneously Treat Severe Calcific Aortic Stenosis and a Large Aortic Root Pseudo-aneurysm in a High-risk Patient

Presenter: Nirat Beohar

June 17, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

Presentation TVT 2016

Study Design for the EVOLUT R Low-Risk Trial

Presenter: Jeffrey J. Popma

June 16, 2016

Presentation TVT 2016

The EVOLUT R TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: James B. Hermiller Jr

June 16, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

Advertisement

Severe PVL, Caused by Ventricular Migration of Evolut R, Successfully Treated With Sapien-3 Valve-in-Valve

Evolut R Snapshots II Techniques to Minimize PPM

Evolut R Snapshots I - The New Evolut R PRO System

The Evolut R TAVR System: A Cool Case, New Technology (Including 34mm), and Clinical Program Updates

TAVR for Pure Aortic Insufficiency (AI) With Prior Ascending Aortic Hemi-shield Repair : Unique Role for EVOLUT-R

Expert Commentary: Evolut R in Degenerative Surgical Aortic Bioprostheses (VIVA Registry)

A Surgeon/Interventionalists Perspectives of Transcatheter Mitral and Tricuspid Valve Therapies Evolution, Impact, and Future Expectations

Impact of Valvular Heart Disease on the Global Burden of Heart Failure: Can Transcatheter Therapies Make a Difference?

TAVR in Perspective Evolution, Impact, and Future Expectations

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

Evolution From a TAVR Program to an Aortic Valve Center of Excellence

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Millipede: Evolution of the Concept

TVT 1039: Transcatheter Aortic Valve Replacement With Evolut-R CoreValve to Simultaneously Treat Severe Calcific Aortic Stenosis and a Large Aortic Root Pseudo-aneurysm in a High-risk Patient

What TAVR Needs Next . . . and What It’s Getting

Study Design for the EVOLUT R Low-Risk Trial

The EVOLUT R TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content